← Back to catalogue

HAtetracell™-C

FDA UDI

Class II (US FDA UDI)

by Innovasis, Inc.

Identity

Trade Name
HAtetracell™-C FDA UDI
Generic Name
Spinal implant trial FDA UDI
Device Name
Trial, 16L x 18W x 11-12H x 12°, SST FDA UDI
Model / Reference
LS-758-24 FDA UDI
Description
Trial, 16L x 18W x 11-12H x 12°, SST FDA UDI

Identifiers

Primary DI / UDI-DI
M711LS758240 FDA UDI
510(k) Number
K231899 FDA UDI
FDA Product Code
ODP FDA UDI
GMDN Term
Spinal implant trial FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
888.3080 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI
Sterilization Method
Moist Heat or Steam Sterilization FDA UDI

Dimensions & Sizes

Size
Length — 16 Millimeter FDA UDI
Width — 18 Millimeter FDA UDI
Angle — 12 degree FDA UDI

Category: Spinal implant trial

HAtetracell™-C by Innovasis, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Spinal implant trial.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Innovasis, Inc.

Sources (1)

  • FDA UDI ac7eb6be-6bf6-4368-a2c7-589dcf90d638 36 fields · synced May 31, 2026